We are live on ! Find out more
DSCI

Derma Sciences
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

55 hedge funds and large institutions have $58.2M invested in Derma Sciences in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 14

7% less funds holding

Funds holding: 59 → 55 (-4)

7.37% less ownership

Funds ownership: 80.57% → 73.2% (-7.4%)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

69% less capital inflows, than outflows

Capital inflows: $3.21M | Capital outflows: $10.4M

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $143K

Holders
55
Holders Change
-4
Holders Change %
-6.78%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
18
Reduced
14
Closed
10
Calls
–
Puts
$143​K
Net Calls
-⁠$143​K
Net Calls Change
-⁠$82​K

DSCI Hedge Fund Activity: Q1 2016 in Review

55 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences (DSCI) for Q1 2016, worth a combined $58.2M — down 39% from $95.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of DSCI and 6 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 18 added.

The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $707K. The largest seller was Consonance Capital Management, cutting an estimated $2.53M.

  • 55 institutional investors held Derma Sciences (DSCI) as of Q1 2016, down from 59 in Q4 2015.
  • Funds reported $58.2M of Derma Sciences stock for Q1 2016, down 39% quarter-over-quarter.
  • 6 funds opened new Derma Sciences positions in Q1 2016 and 10 closed out, a net change of -4 holders.
  • The largest Derma Sciences buyer in Q1 2016 was Manulife (Manufacturers Life Insurance), an estimated $707K added.
  • The largest Derma Sciences seller in Q1 2016 was Consonance Capital Management, an estimated $2.53M sold.

Based on aggregated 13F filings for Q1 2016.